VOYA Investment Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,505
Closed -$157K 2563
2016
Q2
$157K Sell
10,505
-42,410
-80% -$545K ﹤0.01% 2361
2016
Q1
$644K Hold
52,915
﹤0.01% 1542
2015
Q4
$842K Buy
52,915
+18,837
+55% +$297K ﹤0.01% 1374
2015
Q3
$522K Sell
34,078
-3,710
-10% -$80.2K ﹤0.01% 1676
2015
Q2
$919K Hold
37,788
﹤0.01% 1500
2015
Q1
$879K Buy
37,788
+23,573
+166% +$624K ﹤0.01% 1541
2014
Q4
$357K Hold
14,215
﹤0.01% 2161
2014
Q3
$442K Hold
14,215
﹤0.01% 1995
2014
Q2
$368K Hold
14,215
﹤0.01% 2213
2014
Q1
$332K Hold
14,215
﹤0.01% 2263
2013
Q4
$361K Hold
14,215
﹤0.01% 2198
2013
Q3
$290K Hold
14,215
﹤0.01% 2317
2013
Q2
$298K Buy
+14,215
New +$254K ﹤0.01% 2252

VOYA Investment Management's SGNT Position: Q3 2016 in Review

VOYA Investment Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 10,505 shares — an estimated $157K sold.

VOYA Investment Management first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $919K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • VOYA Investment Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • VOYA Investment Management sold 10,505 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $157K.
  • VOYA Investment Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • VOYA Investment Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $919K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on VOYA Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.